These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8695339)

  • 1. Expanded programme on immunization (EPI). Inclusion of yellow fever vaccine in the EPI.
    Wkly Epidemiol Rec; 1996 Jun; 71(24):181-5. PubMed ID: 8695339
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded programme on immunization (EPI). Immunization schedules in the WHO African region, 1995.
    Wkly Epidemiol Rec; 1996 Mar; 71(12):90-4. PubMed ID: 8901335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded programme on immunization (EPI). Progress towards poliomyelitis eradication, 1976-1993.
    Wkly Epidemiol Rec; 1994 Sep; 69(36):268-71. PubMed ID: 7986695
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanded programme on immunization (EPI). Progress toward poliomyelitis eradication, 1995.
    Wkly Epidemiol Rec; 1996 Aug; 71(34):253-5. PubMed ID: 8810877
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of the introduction of the new killed poliomyelitis vaccine into the expanded programme of immunization (EPI).
    Martin JF
    Trop Geogr Med; 1985 Sep; 37(3):S55-9. PubMed ID: 4084367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.
    Cetron MS; Marfin AA; Julian KG; Gubler DJ; Sharp DJ; Barwick RS; Weld LH; Chen R; Clover RD; Deseda-Tous J; Marchessault V; Offit PA; Monath TP
    MMWR Recomm Rep; 2002 Nov; 51(RR-17):1-11; quiz CE1-4. PubMed ID: 12437192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded programme on immunization (EPI). Progress towards poliomyelitis eradication in Africa, 1996.
    Wkly Epidemiol Rec; 1997 Apr; 72(16):109-14. PubMed ID: 9127581
    [No Abstract]   [Full Text] [Related]  

  • 10. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
    O'Brien B; Leggat PA
    Travel Med Infect Dis; 2010 Jul; 8(4):210-2. PubMed ID: 20970723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined vaccines and organization of vaccination campaigns and their relation to antituberculous prevention].
    Labusquiere R
    Med Trop (Mars); 1972; 32(1):55-70. PubMed ID: 5047446
    [No Abstract]   [Full Text] [Related]  

  • 13. ACIP Releases 2018 Childhood Immunization Recommendations.
    Savoy M
    Am Fam Physician; 2018 Feb; 97(4):278. PubMed ID: 29671520
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of yellow fever vaccination centers in Canada.
    Labelle C; Macpherson DW
    J Travel Med; 2005; 12(4):180-3. PubMed ID: 16086891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination rates--assessment and feedback of provider-based vaccination coverage information.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Mar; 45(10):219-20. PubMed ID: 8609879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of anticholera vaccination on associated anti-yellow fever immunization].
    Gateff C; Le Gonidec G; Boche R; Sarrat P; Lemarinier G; Monchicourt D; Labusquière R
    Bull Soc Pathol Exot Filiales; 1973; 66(2):258-66. PubMed ID: 4801953
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estimated operational costs of vaccination campaign to combat yellow fever in Abidjan].
    Zengbe-Acray P; Douba A; Traore Y; Dagnan S; Attoh-Toure H; Ekra D
    Sante Publique; 2009; 21(4):383-91. PubMed ID: 20101817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of immunization in The Gambia.
    Robertson RL; Foster SO; Hull HF; Williams PJ
    J Trop Med Hyg; 1985 Oct; 88(5):343-51. PubMed ID: 3939146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded programme on immunization (EPI). Progress towards the global eradication of poliomyelitis, 1996.
    Wkly Epidemiol Rec; 1997 Jun; 72(26):189-94. PubMed ID: 9220701
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine wastage in The Gambia: a prospective observational study.
    Usuf E; Mackenzie G; Ceesay L; Sowe D; Kampmann B; Roca A
    BMC Public Health; 2018 Jul; 18(1):864. PubMed ID: 29996802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.